Francesco Peri
Francesco Peri
Подтвержден адрес электронной почты в домене unimib.it - Главная страница
Multivalent glycoconjugates as anti-pathogenic agents
A Bernardi, J Jiménez-Barbero, A Casnati, C De Castro, T Darbre, ...
Chemical Society Reviews 42 (11), 4709-4727, 2013
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis
NN Kuzmich, KV Sivak, VN Chubarev, YB Porozov, ...
Vaccines 5 (4), 34, 2017
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice
I Bettoni, F Comelli, C Rossini, F Granucci, G Giagnoni, F Peri, B Costa
Glia 56 (12), 1312-1319, 2008
Chemo-and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates
F Peri, P Dumy, M Mutter
Tetrahedron 54 (40), 12269-12278, 1998
Chemistry of lipid A: at the heart of innate immunity
A Molinaro, O Holst, F Di Lorenzo, M Callaghan, A Nurisso, G D'Errico, ...
Chemistry–A European Journal 21 (2), 500-519, 2015
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
F Peri, M Piazza
Biotechnology advances 30 (1), 251-260, 2012
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update: miniperspective
F Peri, V Calabrese
Journal of medicinal chemistry 57 (9), 3612-3622, 2014
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
H Stabile, S Mitola, E Moroni, M Belleri, S Nicoli, D Coltrini, F Peri, A Pessi, ...
Blood 109 (5), 1834-1840, 2007
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity
A Bianco, V Reghellin, L Donnici, S Fenu, R Alvarez, C Baruffa, F Peri, ...
PLoS pathogens 8 (3), e1002576, 2012
Exploring the LPS/TLR4 signal pathway with small molecules
F Peri, M Piazza, V Calabrese, G Damore, R Cighetti
Biochemical Society Transactions 38 (5), 1390-1395, 2010
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) signalling
F Cochet, F Peri
International journal of molecular sciences 18 (11), 2318, 2017
Electrospinning for drug delivery applications: A review
A Luraghi, F Peri, L Moroni
Journal of Controlled release 334, 463-484, 2021
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
L Perrin-Cocon, A Aublin-Gex, SE Sestito, KA Shirey, MC Patel, P André, ...
Scientific reports 7 (1), 1-13, 2017
Novel Tn antigen-containing neoglycopeptides: synthesis and evaluation as anti tumor vaccines
L Cipolla, M Rescigno, A Leone, F Peri, B La Ferla, F Nicotra
Bioorganic & medicinal chemistry 10 (5), 1639-1646, 2002
Synthesis and Conformational Analysis of Novel N(OCH3)‐linked Disaccharide Analogues
F Peri, J Jiménez–Barbero, V García–Aparicio, I Tvaroška, F Nicotra
Chemistry–A European Journal 10 (6), 1433-1444, 2004
Clustered carbohydrates in synthetic vaccines
F Peri
Chemical Society Reviews 42 (11), 4543-4556, 2013
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization
M Piazza, C Rossini, S Della Fiorentina, C Pozzi, F Comelli, I Bettoni, ...
Journal of medicinal chemistry 52 (4), 1209-1213, 2009
Evidence of a specific interaction between new synthetic antisepsis agents and CD14
M Piazza, L Yu, A Teghanemt, T Gioannini, J Weiss, F Peri
Biochemistry 48 (51), 12337-12344, 2009
Glycoconjugates in cancer therapy
L Cipolla, F Peri, C Airoldi
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope
F Peri, L Cipolla, M Rescigno, B La Ferla, F Nicotra
Bioconjugate chemistry 12 (3), 325-328, 2001
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20